Cannabis and Stimulants: Unraveling Overdose and Psychosis Risks | Silver Hill Hospital

To learn more about the Assessment Program at Silver Hill, visit its webpage.

Cannabis and Stimulants: Unraveling Overdose and Psychosis Risks

The rising rates of overdose incidents, especially among young adults, call for a critical examination of their causes and consequences. Central to this inquiry is the complex relationship between substance use—particularly cannabis and stimulants—and the increasing incidence of psychosis.

In our collaborative CE event with The Dorm, Rocco Marotta, MD, PhD will address the alarming severity of overdose incidents, exploring how brain function, biology, genetic predisposition, and environmental factors contribute to these high overdose rates. Attendees will gain a comprehensive understanding of the connection between substance use, overdose, and psychosis. The presentation will also cover the legal implications of the intertwined crises of substance abuse and overdose, offering key insights for designing effective interventions and policies.

Amanda Fialk, PhD, LCSW, LICSW will lead a dynamic audience Q&A session following the presentation.

REGISTER FOR THE WEBINAR

The Speakers

Rocco Marotta, MD, PhD

Director of the Center for the Treatment and Study of Neuropsychiatric Disorders

Silver Hill Hospital

 

 

Amanda Fialk, PhD, LCSW, LICSW

The Dorm